- The Explorer study: the first double-blind RCT to assess the efficacy of TLC-NOSF on DFUs.
The Explorer study: the first double-blind RCT to assess the efficacy of TLC-NOSF on DFUs.
Journal of wound care (2013-05-15)
D R Shanahan
PMID23665662
ZUSAMMENFASSUNG
Urgo Medical recently announced the launch of the Explorer study, a large, Europe-wide, clinical study on the efficacy and tolerability of UrgoStart Contact, a lipidocolloid technology dressing impregnated with nano-oligosaccharide factor, in the treatment of diabetic foot ulceration. The number of patients, investigating centres and countries involved, as well as the length of treatment and patient follow-up, make this an ambitious, double-blind, randomised controlled trial.
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
Sigma-Aldrich
Natriumcarboxymethylcellulose Natriumsalz, viscosity 50-200 cP , c=4% H2O at 25°C
Sigma-Aldrich
Natriumcarboxymethylcellulose Natriumsalz, average Mw ~250,000, degree of substitution 0.9
Sigma-Aldrich
Natriumcarboxymethylcellulose Natriumsalz, average Mw ~250,000, degree of substitution 0.7
Sigma-Aldrich
Natriumcarboxymethylcellulose Natriumsalz, average Mw ~250,000, degree of substitution 1.2
Sigma-Aldrich
Carboxymethylcellulose Natriumsalz, meets USP testing specifications, Medium viscosity